Cytori Therapeutics

Contact
cytoritx.com
+1858458-0900

Cytori Therapeutics, Inc.

3020 Callan Road
92121 San Diego
USA
+1858458-0900
cytoritx.com
Contact
Profile News
Contact

About Cytori Therapeutics

Cytori Therapeutics is a global leader in the development of regenerative medicine products. The company is developing therapeutic applications for its Celution™ System to enable real-time regenerative cell therapy in conjunction with breast reconstruction surgery, cardiovascular disease, and other unmet medical needs. The Company's StemSource™ Cell Bank, which is based on Cytori's innovative Celution™ System, will be commercialized in Japan starting in 2008 to hospitals and clinics to enable regenerative cell banking.

Read more about Cytori Therapeutics
Facts about Cytori Therapeutics
  • Focus : Manufacturer
  • Industry : Biotechnology

News about Cytori Therapeutics

Cytori Therapeutics

25-Jan-2011 | science

Clinical Experience Shows No Increased Risk of Cancer in Fat Grafting Patients

Published clinical experience in over 2,000 patients who received autologous fat grafts showed no evidence of increased risk of development, metastasis or ...

Read news
Cytori Therapeutics

16-Dec-2009 | research and development

Cytori Reports Promising Results in Cell-Enriched Breast Reconstruction Trial

Interim results from a European clinical trial, RESTORE 2, demonstrate that cell-enriched breast reconstruction achieved a high rate of patient and ...

Read news
Cytori Therapeutics

23-Jun-2008 | politics & laws

Court Determines that University of Pittsburgh and Artecel Have Sole Rights to Adipose-Derived Stem Cell Patent

Artecel, Inc., announced that the patent inventorship litigation concerning the foundational, composition-of-matter patent covering stem cells isolated ...

Read news
Cytori Therapeutics

19-Dec-2007 | research and development

Adipose-Derived Stem & Regenerative Cells Improve Fat Graft Retention in Preclinical Study

Cytori Therapeutics, Inc. reported positive preclinical results demonstrating adipose-derived stem and regenerative cells improved the quality and longterm ...

Read news
Cytori Therapeutics

08-Nov-2007 | research and development

Cytori's Celution System Under Evaluation for Breast Augmentation as Part of Investigator Initiated Study

A new study underway in Japan will examine the effect of adult stem and regenerative cells derived from adipose tissue in breast augmentation. In this ...

Read news
Cytori Therapeutics

24-Oct-2007 | science

Adipose Stem & Regenerative Cells Not Linked to Arrhythmias in Preclinical Study

Important Safety Findings Published in EuroPace Cardiology Journal

Read news
Cytori Therapeutics

21-Sep-2007 | research and development

Cytori awarded NIH Grant to develop cell-based treatments for vascular disease

Cytori Therapeutics was awarded a $250,000 NIH (National Institutes of Health) Grant to develop adipose-derived regenerative cells as a treatment for ...

Read news
Cytori Therapeutics

28-Jun-2007 | business & finance

Cytori Therapeutics to Voluntarily Delist From the Frankfurt Stock Exchange to Consolidate Trading on the NASDAQ Global Market

Cytori Therapeutics is voluntarily delisting from the Frankfurt Stock Exchange (FSE). The move is primarily in response to the significant shift in trading ...

Read news
Show more news about Cytori Therapeutics

Here you will find Cytori Therapeutics, Inc.